Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus
Aleš Goropevšek, Marija Holcar, Tadej Avčin
Clinical Reviews in Allergy & Immunology (2016) Vol. 52, Iss. 2, pp. 164-181
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 234
Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
Takayuki Katsuyama, George C. Tsokos, Vaishali R. Moulton
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 189
Bystander activation and autoimmunity
Y. Pachéco, Yeny Acosta‐Ampudia, Diana M. Monsalve, et al.
Journal of Autoimmunity (2019) Vol. 103, pp. 102301-102301
Closed Access | Times Cited: 167
Current prospects of type II interferon γ signaling and autoimmunity
Daniel S. Green, Howard A. Young, Julio C. Valencia
Journal of Biological Chemistry (2017) Vol. 292, Iss. 34, pp. 13925-13933
Open Access | Times Cited: 151
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Jeffrey M. Riggs, Richard N. Hanna, Bhargavi Rajan, et al.
Lupus Science & Medicine (2018) Vol. 5, Iss. 1, pp. e000261-e000261
Open Access | Times Cited: 118
Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus
Guo‐Cui Wu, Jun Li, Rui‐Xue Leng, et al.
Oncotarget (2017) Vol. 8, Iss. 14, pp. 23650-23663
Open Access | Times Cited: 113
STAT4: an immunoregulator contributing to diverse human diseases
Chou Yang, Haoming Mai, Jinxin Peng, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 9, pp. 1575-1585
Open Access | Times Cited: 93
Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies
Aimi Syamima Abdul Manap, Aini Athirah Wisham, Fei Wen Wong, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Different expression patterns of plasma Th1‐, Th2‐, Th17‐ and Th22‐related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria
Qiquan Chen, Hua Zhong, Wei-Ling Chen, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 32, Iss. 3, pp. 441-448
Closed Access | Times Cited: 73
Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE
Thomas Dörner, Peter E. Lipsky
Nature Reviews Rheumatology (2016) Vol. 12, Iss. 11, pp. 645-657
Closed Access | Times Cited: 67
Confirmation of five novel susceptibility loci for Systemic Lupus Erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci
Julio E. Molineros, Wanling Yang, Shufeng Zhou, et al.
Human Molecular Genetics (2017), pp. ddx026-ddx026
Open Access | Times Cited: 63
The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives
Sayeh Mottaghi, Hassan Abbaszadeh
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6843-6861
Closed Access | Times Cited: 46
Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
Tao Cheng, Shuai Ding, Shanshan Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
Elvira Favoino, Marcella Prete, Giacomo Catacchio, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 3, pp. 102750-102750
Closed Access | Times Cited: 42
Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus
Chuang Guo, Qian Liu, Dandan Zong, et al.
Cell Reports (2022) Vol. 41, Iss. 6, pp. 111606-111606
Closed Access | Times Cited: 38
Disease activity drives divergent epigenetic and transcriptomic reprogramming of monocyte subpopulations in systemic lupus erythematosus
Anna G. Ferreté-Bonastre, Mónica Martínez‐Gallo, Octavio Morante-Palacios, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 7, pp. 865-878
Closed Access | Times Cited: 8
Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2–STAT3 signaling pathway
Wenzhen Dang, Hui Li, Bing‐Hua Jiang, et al.
Phytomedicine (2019) Vol. 62, pp. 152965-152965
Closed Access | Times Cited: 50
Tissue Treg Secretomes and Transcription Factors Shared With Stem Cells Contribute to a Treg Niche to Maintain Treg-Ness With 80% Innate Immune Pathways, and Functions of Immunosuppression and Tissue Repair
Ruijing Zhang, Keman Xu, Ying Shao, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 39
Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis
Izabela Woś, Jacek Tabarkiewicz
Immunologic Research (2021) Vol. 69, Iss. 1, pp. 26-42
Open Access | Times Cited: 36
Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
Sara La Manna, Ilaria De Benedictis, Daniela Marasco
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 23
Exploring pectin-casein micelles as novel carriers for oral drug delivery of artesunate in the treatment of systemic lupus erythematosus
Yuanyuan Zhang, Yongbin Meng, Siying Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132523-132523
Closed Access | Times Cited: 5
Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells
N-S Lai, Malcolm Koo, C-L Yu, et al.
Clinical & Experimental Immunology (2016) Vol. 187, Iss. 3, pp. 327-336
Open Access | Times Cited: 43
A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus
Zubin Patel, Xiaoming Lu, Daniel Miller, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 13, pp. 2392-2404
Open Access | Times Cited: 40
Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus
Shih‐Yao Chen, Ming-Fei Liu, Pin-Yu Kuo, et al.
Clinical Rheumatology (2019) Vol. 38, Iss. 5, pp. 1361-1366
Closed Access | Times Cited: 40
Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients
Chen Chen, Jun Liang, Genhong Yao, et al.
International Immunopharmacology (2017) Vol. 44, pp. 234-241
Closed Access | Times Cited: 38
Page 1 - Next Page

Scroll to top